Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Convertible Debt (2020 - 2025)

Collegium Pharmaceutical (COLL) has 6 years of Convertible Debt data on record, last reported at $238.0 million in Q3 2025.

  • For Q3 2025, Convertible Debt changed 0.44% year-over-year to $238.0 million; the TTM value through Sep 2025 reached $238.0 million, changed 0.44%, while the annual FY2024 figure was $237.2 million, 9.52% down from the prior year.
  • Convertible Debt reached $238.0 million in Q3 2025 per COLL's latest filing, roughly flat from $237.7 million in the prior quarter.
  • Across five years, Convertible Debt topped out at $262.4 million in Q1 2024 and bottomed at $26.4 million in Q1 2022.
  • Average Convertible Debt over 5 years is $196.8 million, with a median of $236.9 million recorded in 2024.
  • Peak YoY movement for Convertible Debt: tumbled 81.08% in 2022, then soared 891.35% in 2023.
  • A 5-year view of Convertible Debt shows it stood at $140.0 million in 2021, then rose by 0.65% to $140.9 million in 2022, then soared by 86.07% to $262.1 million in 2023, then dropped by 9.52% to $237.2 million in 2024, then rose by 0.33% to $238.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Convertible Debt were $238.0 million in Q3 2025, $237.7 million in Q2 2025, and $237.4 million in Q1 2025.